Trial Profile
A Phase 2, Randomized, Double-blind, Placebo-controlled, Multicenter, Dose-ranging Study of Cicletanine in Subjects With Pulmonary Arterial Hypertension
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Cicletanine (Primary)
- Indications Pulmonary arterial hypertension
- Focus Therapeutic Use
- Sponsors Gilead Sciences
- 15 May 2014 New trial record